There comes a point in every business when reality hits you like a ton of bricks. When it comes to diabetes Medtronic seems to have reached that point. Just as quick review after years of absolutely dominating the insulin pump market, owning formulary and bringing out innovative product offerings the company has since been leapfrogged by the competition. The Control IQ from Tandem now is the coolest toy in the insulin pump toy chest becoming the standard from which all hybrid closed loop systems will be judged against. Insulet with their move to the pharmacy continues to gain share and . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.